Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled date : 2021 - 11 - 15 save search
InflaRx Announces Positive Data from Phase II IXCHANGE Study with Vilobelimab in ANCA-associated Vasculitis (AAV)
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
IFRX | $1.36 -0.37% 71K
|
Health Technology
|
| O: -1.97%
H: 3.94%
C: -10.42%
positive
Immutep Publishes AIPAC, TACTI-002 and TACTI-003 Trial Posters at SITC with Positive New Data for LAG-3 Therapy, Eftilagimod Alpha
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: 0.47%
H: 1.16%
C: -0.93%
positive therapy trial
AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line Data
Published: 2021-11-15 (Crawled : 14:00) - ir.anaptysbio.com
ANAB | $19.27 0.47% 0.36% 390K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
phase 1 positive topline phase 2 phase 3
Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Published: 2021-11-15 (Crawled : 14:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 2.19%
H: 0.0%
C: 0.0%
phase 2 positive
Lear to Supply Advanced Connectivity and Vehicle Positioning Solutions to Global Electric Vehicle Manufacturer
Published: 2021-11-15 (Crawled : 13:30) - prnewswire.com
LEA | $135.17 1.23% 0.0% 450K
|
Producer Manufacturing
|
| O: 4.36%
H: 1.44%
C: 1.39%
electric vehicle positive
SHARC Energy Files Record Breaking Revenue and First Cash Flow Positive Quarter
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
INTWF | $0.1588 14.25% 0% 0
|
Producer Manufacturing
|
| O: -2.74%
H: 0.0%
C: -5.94%
energy positive
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RCKT 4 | $23.63 -0.17% -0.13% 920K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: -23.94%
disease phase 1 positive trial phase 2 phase 3 rp-a501 danon disease
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
NVCR | $12.34 2.36% 2.39% 1.3M
|
Health Technology
|
| O: 3.0%
H: 0.39%
C: -3.17%
phase 2 positive results trial topline glioblastoma
Protagonist Therapeutics Announces Positive Phase 2a Data Supporting the Potential Use of Rusfertide as a First-in-Class Therapy in Hereditary Hemochromatosis
Published: 2021-11-15 (Crawled : 12:00) - prnewswire.com
PTGX S | $25.7 -4.28% -4.56% 330K
|
Health Technology
|
| O: 4.69%
H: 0.0%
C: 0.0%
phase 2 potential positive therapy phase 2b
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.